Triple-negative breast cancer responds to new dual-target therapy
An experimental therapy that targets two growth pathways reduced cancer cell proliferation and spread in mice with triple-negative breast cancer.
More... |
All times are GMT -7. The time now is 08:54 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021